ChlorprophamThrombocytopeniaAnemia, RefractoryAnemia, Refractory, with Excess of BlastsSyndromeLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, AcuteChromosomes, Human, Pair 5Platelet CountLeukemia, MyeloidBone MarrowAzacitidineAnemia, SideroblasticChromosome AberrationsThalidomideKaryotypingMonosomyPancytopeniaMyeloproliferative DisordersPreleukemiaPurpura, Thrombocytopenic, IdiopathicTreatment OutcomeAnemia, AplasticMyelodysplastic-Myeloproliferative DiseasesChromosomes, Human, Pair 7Thrombocytopenia, Neonatal AlloimmunePrognosisAcute DiseaseCytogenetic AnalysisBone Marrow CellsLeukemiaMegakaryocytesChromosome DeletionPlatelet TransfusionBone Marrow DiseasesGranulocyte Precursor CellsThrombopoietinAntimetabolites, AntineoplasticHematologic AgentsHematopoietic Stem Cell TransplantationNeoplasms, Second PrimaryBlood Cell CountBlood PlateletsSurvival AnalysisErythrocyte TransfusionIron OverloadTrisomyHematologic DiseasesCytogeneticsFluspirileneBlood TransfusionHematopoietic Stem CellsAntineoplastic Combined Chemotherapy ProtocolsAnemiaRemission InductionTransplantation, HomologousAntineoplastic AgentsBone Marrow ExaminationHematopoiesisHumoralismErythropoietinAntigens, CD34Granulocyte Colony-Stimulating FactorNeutropeniaChelation TherapyRetrospective StudiesCytarabineAntigens, Human PlateletDown SyndromeDrug Administration ScheduleBlast CrisisThrombocytosisDisease ProgressionMutationTransplantation ConditioningMetabolic Syndrome XVidarabinePrimary MyelofibrosisEuglenidaFatal OutcomeIn Situ Hybridization, FluorescenceSweet SyndromeCore Binding Factor Alpha 2 SubunitAnemia, MacrocyticRecurrenceChromosomes, Human, Pair 8Flow CytometryPlatelet Factor 4Chromosome DisordersRisk FactorsHematologic NeoplasmsBone Marrow TransplantationHaploinsufficiencyKaryotypeErythroid Precursor CellsDisease-Free SurvivalTranslocation, GeneticChromosomes, Human, Pair 20HematologyIron Chelating Agents